Germany’s Merck KGaA is in advanced talks to aquire the U.S. biopharmaceutical company that specializes in rare diseases and cancer.
Women, immigrants and the LGBTQIA+ community responded to the fraught geopolitical climate with their catwalk shows ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback